Precision Biosciences (DTIL) Short-term Investments (2024 - 2026)

Precision Biosciences (DTIL) has 3 years of Short-term Investments data on file, last reported at $1.8 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $1.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (changed N/A YoY), and the FY2025 annual result was $4.8 million, up 1053.03% from the prior year.
• Short-term Investments declined to $1.8 million in Q1 2026 per DTIL's latest filing, from $4.8 million in the prior quarter.
• Over five years, Short-term Investments peaked at $4.8 million in Q4 2025 and troughed at $413000.0 in Q4 2024.
• A 3-year average of $2.4 million and a median of $2.1 million in 2024 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 1053.03% in 2025 and fell as far as 1053.03% in 2025.
• A 3-year view of Short-term Investments shows it stood at $413000.0 in 2024, then soared by 1053.03% to $4.8 million in 2025, then slumped by 61.91% to $1.8 million in 2026.
• Business Quant data shows DTIL's Short-term Investments at $1.8 million in Q1 2026, $4.8 million in Q4 2025, and $413000.0 in Q4 2024.